| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/02/2013 | US8410253 Scavenger receptor |
| 04/02/2013 | US8410252 ULBP2 polypeptides |
| 04/02/2013 | US8410162 Choline esters |
| 04/02/2013 | US8410074 Modulation of eIF4E expression |
| 04/02/2013 | US8410072 Use of a growth-stimulating protein |
| 04/02/2013 | US8410071 Potent LNA oligonucleotides for the inhibition of HIF-1A expression |
| 04/02/2013 | US8410070 Compositions and methods for treating cancer, inhibiting proliferation, and inducing cell death |
| 04/02/2013 | US8410069 Oligoribonucleotide inhibitors of Nrf2 and methods of use thereof for treatment of cancer |
| 04/02/2013 | US8410068 Compounds for the treatment or alleviation of edema, and methods for their use |
| 04/02/2013 | US8410067 Inhibition of versican with siRNA and other molecules |
| 04/02/2013 | US8410061 Variants of hedgehog protein that contain N-terminal modifications are described that can block hedgehog function; thus allowing these variants to serve as functional antagonists. These peptides have a primary amino acid sequence |
| 04/02/2013 | US8410051 FGF21 mutants and uses thereof |
| 04/02/2013 | US8409861 Targeted deletion of cellular DNA sequences |
| 04/02/2013 | US8409859 Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype |
| 04/02/2013 | US8409857 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| 04/02/2013 | US8409856 Compositions and their uses directed to gemin genes |
| 04/02/2013 | US8409843 Multi plasmids system for the production of influenza virus |
| 04/02/2013 | US8409842 Recombinant adeno-associated virus production |
| 04/02/2013 | US8409841 Hydroxynitrile lyase |
| 04/02/2013 | US8409838 Fucosylation-deficient cells |
| 04/02/2013 | US8409835 Method for producing xylitol from lignocellulosic hydrolysates without detoxification |
| 04/02/2013 | US8409833 Method for producing scyllo-inositol |
| 04/02/2013 | US8409826 TAT-utrophin as a protein therapy for dystrophinopathies |
| 04/02/2013 | US8409825 Method for high-level secretory production of protein |
| 04/02/2013 | US8409813 Treatment of cancer using TLR3 agonists |
| 04/02/2013 | US8409800 Nucleic acid based fluorescent sensor for copper detection |
| 04/02/2013 | US8409796 Method of regulating gene expression |
| 04/02/2013 | US8409588 Recombinant foot and mouth disease vaccine |
| 04/02/2013 | US8409578 Methods for treating bone loss with antibodies to OPGL |
| 04/02/2013 | US8409575 Antibodies specific for amyloid beta protofibril |
| 04/02/2013 | US8409572 Monoclonal antibodies with enhanced ADCC function |
| 04/02/2013 | US8409566 Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis |
| 04/02/2013 | CA2627247C Hepatitis c virus ns2/3 activity assay |
| 04/02/2013 | CA2565466C Cell preparation |
| 04/02/2013 | CA2553883C Anti-cancer antibodies with reduced complement fixation |
| 04/02/2013 | CA2532799C Human antibody molecules for il-13 |
| 04/02/2013 | CA2505776C Plant cells and plants which synthesize a starch with an increased final viscosity |
| 04/02/2013 | CA2502431C Method for the manufacture of nucleic acid molecules |
| 04/02/2013 | CA2483997C A modified yeast consuming l-arabinose |
| 04/02/2013 | CA2472647C Mammal prolactin variants |
| 04/02/2013 | CA2471145C Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents |
| 04/02/2013 | CA2460392C Recombinant allergen with reduced ige binding but undiminished t-cell antigenicity |
| 04/02/2013 | CA2457611C Novel molecular target for neurotoxicity |
| 04/02/2013 | CA2453062C Group b streptococcus bvh-a5 antigens and corresponding dna fragments |
| 04/02/2013 | CA2449412C Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 04/02/2013 | CA2443411C Overexpression of phosphoenolpyruvate carboxylase |
| 04/02/2013 | CA2425794C Nucleic acid molecules associated with plant cell proliferation and growth and uses thereof |
| 04/02/2013 | CA2420543C Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 04/02/2013 | CA2402131C Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 04/02/2013 | CA2396212C Recombinant antibodies to human interleukin-1 beta |
| 04/02/2013 | CA2364294C Testing endosymbiont cellular organelles and compounds identifiable therewith |
| 04/02/2013 | CA2201282C Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 03/30/2013 | CA2788722A1 Polypeptides having glucose dehydrogenase activity and polynucleotides encoding same |
| 03/28/2013 | WO2013044076A1 Direct biocatalytic production of acrylic acid and other carboxylic acid compounds |
| 03/28/2013 | WO2013044029A1 Methods and compositions for expanding cells and improving engraftment |
| 03/28/2013 | WO2013044023A2 Citrus tristeza virus based vectors for foreign gene/s expression |
| 03/28/2013 | WO2013044008A2 Methods and compositions for regulation of transgene expression |
| 03/28/2013 | WO2013043910A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 03/28/2013 | WO2013043853A1 Tobacco having reduced amounts of amino acids and methods for producing such lines |
| 03/28/2013 | WO2013043817A1 Antisense modulation of gcgr expression |
| 03/28/2013 | WO2013043777A1 Pathogen resistance |
| 03/28/2013 | WO2013043666A2 Tomato catechol-o-methyltransferase sequences and methods of use |
| 03/28/2013 | WO2013043638A1 Monomer architecture of tal nuclease or zinc finger nuclease for dna modification |
| 03/28/2013 | WO2013043459A1 Shigella-derived vector and methods of using the same |
| 03/28/2013 | WO2013043442A1 The introduction of modular vector elements during production of a lentivirus |
| 03/28/2013 | WO2013043317A1 Endoglucanase 1b |
| 03/28/2013 | WO2013043196A1 Improved gene therapy methods |
| 03/28/2013 | WO2013043041A2 Methods and compositions for diagnosing familial hypercholesterolemia |
| 03/28/2013 | WO2013043012A2 Novel use of leucyl trna synthetase |
| 03/28/2013 | WO2013042821A1 Selection of a permissive site for protein redesign, and method for producing a modified protein using same |
| 03/28/2013 | WO2013042731A1 Simple method for detecting pluripotent stem cells genetically modified by homologous recombination |
| 03/28/2013 | WO2013042077A1 Diagnosis of tuberculosis |
| 03/28/2013 | WO2013041846A2 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics |
| 03/28/2013 | WO2013041845A2 Animals, repertoires & methods |
| 03/28/2013 | WO2013041844A2 Antibodies, variable domains & chains tailored for human use |
| 03/28/2013 | WO2013041725A1 Fibroblasts cellular model for assessing efficacy of cancer treatments by SHH/PTCH pathway antagonists |
| 03/28/2013 | WO2013041724A1 Human keratinocytes ptch1 cell line |
| 03/28/2013 | WO2013041643A1 Screening methods and uses thereof |
| 03/28/2013 | WO2013041588A1 A method of detecting active tb |
| 03/28/2013 | WO2013041500A1 Microbubble complexes and methods of use |
| 03/28/2013 | WO2013041487A1 Co2 profile cultivation |
| 03/28/2013 | WO2013041238A1 Use of kibra peptides, hdac inhibitor or proteasome inhibitor for improving anxiety disorders |
| 03/28/2013 | WO2013041223A1 Crystal structure of the 60s eukaryotic ribosomal subunit and its uses |
| 03/28/2013 | WO2013041029A1 Novel soluble ctla4 variants |
| 03/28/2013 | WO2013040992A1 Double-stranded nucleic acid, use and kit thereof in ribonuclease detection |
| 03/28/2013 | WO2013040766A1 Method and vaccine capable of inducing broad spectrum immune response against hiv |
| 03/28/2013 | WO2013040688A1 Enhancement of eukaryotic cell properties using ultrasound |
| 03/28/2013 | WO2013040650A1 Screening method |
| 03/28/2013 | WO2013016428A9 Recombinant apoa-1m from engineered bacteria |
| 03/28/2013 | WO2013016315A8 Methods for treating niemann-pick type c disease |
| 03/28/2013 | WO2013009143A9 Marker for diagnosing diabetic retinopathy |
| 03/28/2013 | WO2013009084A9 Composition for simultaneously detecting mycobacterium tuberculosis and nontuberculous mycobacteria by means of real-time multiplex polymerase chain reaction comprising nested hybridization pna probe system having parallel binding structure, and method for detection using same |
| 03/28/2013 | WO2013009070A3 Nested hybridization pna probe system having parallel binding structure |
| 03/28/2013 | WO2013003585A3 Enrichment of nucleic acids by complimentary capture |
| 03/28/2013 | WO2012178150A3 Methods for developing antigen-specific antibody-producing cell lines and monoclonal antibodies |
| 03/28/2013 | WO2012177921A3 Compositions and methods for inhibiting hepcidin antimicrobial peptide (hamp) or hamp-related gene expression |
| 03/28/2013 | WO2012177655A9 Methods and systems for tracking bioremediation processes |
| 03/28/2013 | WO2012174187A3 Methods, compositions, and kits for determining human immunodeficiency virus (hiv) |
| 03/28/2013 | WO2012173344A3 Expression vector for animal cells including csp-b 5'-sar factor and method for producing recombinant proteins using same |
| 03/28/2013 | WO2012170768A9 Hybrid tomatoes and methods of making hybrid tomatoes |